1. |
中华医学会消化病学分会炎症性肠病学组. 炎症性肠病诊断与治疗的共识意见 (2012 年·广州). 胃肠病学, 2012, 17(12): 763-781.
|
2. |
Torres J, Mehandru S, Colombel JF, et al. Crohn’s disease. Lancet, 2017, 389(10080): 1741-1755.
|
3. |
Nishida A, Inoue R, Inatomi O, et al. Gut microbiota in the pathogenesis of inflammatory bowel disease. Clin J Gastroenterol, 2018, 11(1): 1-10.
|
4. |
Ramos GP, Papadakis KA. Mechanisms of disease: inflammatory bowel diseases. Mayo Clin Proc, 2019, 94(1): 155-165.
|
5. |
Thia KT, Sandborn WJ, Harmsen WS, et al. Risk factors associated with progression to intestinal complications of Crohn’s disease in a population-based cohort. Gastroenterology, 2010, 139(4): 1147-1155.
|
6. |
Lee DW, Koo JS, Choe JW, et al. Diagnostic delay in inflammatory bowel disease increases the risk of intestinal surgery. World J Gastroenterol, 2017, 23(35): 6474-6481.
|
7. |
Coward S, Clement F, Benchimol EI, et al. Past and future burden of inflammatory bowel diseases based on modeling of population-based data. Gastroenterology, 2019, 156(5): 1345-1353.
|
8. |
Ng SC, Shi HY, Hamidi N, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet, 2018, 390(1114): 2769-2778.
|
9. |
Wang YF, Ouyang Q, Hu RW. Progression of inflammatory bowel disease in China. J Dig Dis, 2010, 11(2): 76-82.
|
10. |
Ng SC, Tang W, Ching JY, et al. Incidence and phenotype of inflammatory bowel disease based on results from the Asia-Pacific Crohn’s and Colitis Epidemiology Study. Gastroenterology, 2013, 145(1): 158-165.
|
11. |
钱家鸣, 杨红. 中国炎症性肠病研究的历史回顾、现状和展望. 中国实用内科杂志, 2015, 35(9): 727-730.
|
12. |
Kaplan GG, Ng SC. Globalisation of inflammatory bowel disease: perspectives from the evolution of inflammatory bowel disease in the UK and China. Lancet Gastroenterol Hepatol, 2016, 1(4): 307-316.
|
13. |
APDW 2004 Chinese IBD Working Group. Retrospective analysis of 515 cases of Crohn’s disease hospitalization in China: nationwide study from 1990 to 2003. J Gastroenterol Hepatol, 2006, 21(6): 1009-1015.
|
14. |
Chen X, Yang K, Xu Y, et al. Top-100 highest-cited original articles in inflammatory bowel disease: a bibliometric analysis. Medicine, 2019, 98(20): e15718.
|
15. |
郑家驹, 史肖华, 竺霞霜, 等. 我国克罗恩病不同年代发病率及患病率的比较. 中华内科杂志, 2011, 50(7): 597-600.
|
16. |
Chen JM, Liu T, Gao S, et al. Efficacy of noninvasive evaluations in monitoring inflammatory bowel disease activity: a prospective study in China. World J Gastroenterol, 2017, 23(46): 8235-8247.
|
17. |
木婧熙, 张虎. 肠道超声学检查在克罗恩病中的应用及前景. 华西医学, 2019, 34(4): 448-453.
|
18. |
Pai RK, Jairath V. What is the role of histopathology in the evaluation of disease activity in Crohn’s disease?. Best Pract Res Clin Gastroenterol, 2019, 38-39: 10601.
|
19. |
Hart L, Bessissow T. Endoscopic scoring systems for the evaluation and monitoring of disease activity in Crohn’s disease. Best Pract Res Clin Gastroenterol, 2019, 38-39: 101616.
|
20. |
Ma C, Battat R, Khanna R, et al. What is the role of C-reactive protein and fecal calprotectin in evaluating Crohn’s disease activity?. Best Pract Res Clin Gastroenterol, 2019, 38-39: 101602.
|
21. |
Romagnoni A, Jégou S, Van Steen K, et al. Comparative performances of machine learning methods for classifying Crohn Disease patients using genome-wide genotyping data. Sci Rep, 2019, 9(1): 10351.
|
22. |
Uniken Venema WT, Voskuil MD, Vila AV, et al. Single-cell RNA sequencing of blood and ileal T cells from patients with Crohn’s disease reveals tissue-specific characteristics and drug targets. Gastroenterology, 2019, 156(3): 812-815.
|
23. |
欧阳钦, 彭清海, 张萃. 炎症性肠病多学科协作诊治团队的建设与发展. 内科急危重症杂志, 2015, 21(1): 1-3.
|
24. |
杨建波, 龚剑峰, 李毅, 等. 术前 CT 小肠造影预测克罗恩病与术中探查结果的一致性分析. 中华胃肠外科杂志, 2017(5): 555-559.
|
25. |
Scoville EA, Schwartz DA. Endoscopy in inflammatory bowel disease: advances in disease management. Gastrointest Endosc, 2017, 86(6): 952-961.
|
26. |
Takenaka K, Ohtsuka K, Kitazume Y, et al. Utility of magnetic resonance enterography for small bowel endoscopic healing in patients with Crohn’s disease. Am J Gastroenterol, 2018, 113(2): 283-294.
|
27. |
Dulai PS, Peyrin-Biroulet L, Danese S, et al. Approaches to integrating biomarkers into clinical trials and care pathways as targets for treatment of inflammatory bowel diseases. Gastroenterology, 2019, 157(4): 1032-1043.
|
28. |
Bettenworth D, Bokemeyer A, Baker M, et al. Assessment of Crohn’s disease-associated small bowel strictures and fibrosis on cross-sectional imaging: a systematic review. Gut, 2019, 68(6): 1115-1126.
|